CA
QTTB icon

Clearstead Advisors’s Q32 Bio QTTB Stock Holding History

Clearstead Advisors’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$854 Buy
+67
New +$560 ﹤0.01% 2746

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Clearstead Advisors's QTTB Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Q32 Bio (QTTB) in Q2 2026: 67 shares worth $854. The stake represents ﹤0.01% of the portfolio and ranks #2746 among its holdings.

72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Clearstead Advisors held 67 shares of Q32 Bio worth $854 as of Q2 2026.
  • Q32 Bio was a new Clearstead Advisors position in Q2 2026.
  • Q32 Bio made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2746 holding.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.